Miglitol Tablet, Coated
Product Images NDC 69367-303

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Miglitol (NDC 69367-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg Tablet Bottle Label (4000882 Miglitol 25mg (wp)(v.1) 201028 For Elisting)

Miglitol Tablets 25 mg label showing a prescription drug by Westminster Pharmaceuticals, LLC. The label indicates 100 coated tablets per package and provides storage instructions. It includes manufacturer information from Orient Pharma Co., Ltd., Yunlin, Taiwan, and Westminster Pharmaceuticals, LLC, Nashville, TN.*

FDA Label Image

50 mg Tablet Bottle Label (4000883 Miglitol 50mg (wp)(v.1) 201028 For Elisting)

Miglitol 50 mg coated tablets bottle label showing 100 tablets. Label includes storage temperatures, dosing instruction reference, manufacturer Orient Pharma Co., Ltd. Taiwan, and labeler Westminster Pharmaceuticals, LLC, Nashville, TN. Contains a barcode and NDC 69367-304-01.*

FDA Label Image

100 mg Tablet Bottle Label (4000884 Miglitol 100mg (wp)(v.1) 201028 For Elisting)

Miglitol Tablets 100 mg label with 100 tablets count by Westminster Pharmaceuticals, LLC. The label includes storage instructions, manufacturer info (Orient Pharma Co., Ltd., Taiwan), and a barcode. It states each film-coated tablet contains 100 mg of miglitol and is for prescription use only.*

FDA Label Image

1c5a6b7-900b-4eff-ac99-1df08fa33854 (41c5a6b7 900b 4eff Ac99 1df08fa33854)

Two bar graphs showing the treatment effect of Miglitol at doses of 25 mg, 50 mg, and 100 mg three times daily (tid) based on pooled results from controlled fixed-dose studies. Figure 1 illustrates mean change from baseline in HbA1c (%) with decreasing values at higher doses. Figure 2 depicts mean change from baseline in 1-hour postprandial plasma glucose (mg/dL), showing progressively greater decreases at higher doses.*

FDA Label Image

Abcdea2-1f08-4f44-bac7-e6a43bc5a32f (Eabcdea2 1f08 4f44 Bac7 E6a43bc5a32f)

Chemical structure of miglitol. The diagram shows the molecular layout with labeled hydroxyl (OH) groups and nitrogen atom in a bicyclic arrangement corresponding to the active ingredient miglitol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.